Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robot ultrasound vs handheld: which is better for breast cancer checks?

NCT ID NCT05408260

First seen Jan 09, 2026 · Last updated Jun 20, 2026 · Updated 21 times

Summary

This study looked at whether an automated breast ultrasound (ABUS) machine can be used instead of a handheld ultrasound (HHUS) to screen for breast cancer in women who have had breast reconstruction after cancer. Twelve women who had nipple-sparing or skin-sparing mastectomy with reconstruction were scanned with both methods. The goal was to see if ABUS could detect leftover tissue (artifacts) as well as HHUS. If it works, ABUS could offer a more standardized and less operator-dependent screening option.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT BREAST NEOPLASM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Sidney Kimmel Cancer Center at Thomas Jefferson University

    Philadelphia, Pennsylvania, 19107, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Ultrasound imaging (automated and handheld)

What this could lead to

If successful, this could show that automated breast ultrasound is a reliable, easier option for routine cancer surveillance in women who have had breast reconstruction.

What could go wrong

This is a very small, early feasibility study with only 12 participants. It does not measure cancer detection directly, only imaging artifacts, so results may not change practice.

Conditions

The condition(s) this trial relates to.

breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.